Christopher Raymond
Stock Analyst at Raymond James
(2.85)
# 2,702
Out of 4,399 analysts
877
Total ratings
43.9%
Success rate
1.2%
Average return
Main Sectors:
Stocks Rated by Christopher Raymond
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NUVL Nuvalent | Downgraded: Hold | n/a | $123.35 | - | 14 | Jun 9, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | n/a | $56.17 | - | 86 | May 22, 2026 | |
| CLYM Climb Bio | Maintained: Buy | n/a | $10.80 | - | 2 | May 19, 2026 | |
| ALMS Alumis | Maintained: Buy | $46 | $20.06 | +129.31% | 2 | Mar 27, 2026 | |
| BHVN Biohaven | Maintained: Buy | n/a | $11.07 | - | 21 | Mar 9, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | $35 → $55 | $25.42 | +116.37% | 7 | Feb 23, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $723 → $870 | $601.65 | +44.60% | 114 | Jan 30, 2026 | |
| COGT Cogent Biosciences | Maintained: Buy | $60 | $31.38 | +91.20% | 20 | Jan 26, 2026 | |
| LXEO Lexeo Therapeutics | Maintained: Buy | $25 | $4.13 | +505.33% | 2 | Jan 13, 2026 | |
| ARDX Ardelyx | Maintained: Buy | $14 → $19 | $5.61 | +238.68% | 41 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $47 | $3.48 | +1,250.57% | 1 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $5.40 | +140.74% | 6 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $142 → $123 | $59.73 | +105.93% | 5 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 → $29 | $9.14 | +217.29% | 11 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $337.73 | - | 78 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $4.18 | +450.24% | 14 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $533 → $401 | $435.71 | -7.97% | 26 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $4.10 | n/a | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 | $22.97 | n/a | 58 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $4 | $12.87 | n/a | 6 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $98.03 | n/a | 5 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $220 → $227 | $224.95 | n/a | 84 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $75 | $9.11 | n/a | 21 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $307 → $315 | $194.24 | n/a | 91 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $8.19 | n/a | 19 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $56 | $28.88 | n/a | 11 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.008 | n/a | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 → $8 | $1.46 | n/a | 24 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 | $73.38 | n/a | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.8729 | n/a | 22 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $600 | $862.18 | n/a | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $22 | $46.74 | n/a | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $2.35 | n/a | 1 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 | $0.9315 | n/a | 5 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $38.00 | n/a | 1 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $5.96 | n/a | 6 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $75 → $30 | $6.61 | n/a | 5 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $6 | $1.09 | n/a | 20 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $30.91 | n/a | 12 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.6674 | n/a | 4 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $33.58 | n/a | 1 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.78 | n/a | 6 | Aug 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $42 → $101 | - | n/a | 2 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.001 | n/a | 6 | Mar 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3 → $6 | $2.56 | n/a | 3 | Feb 29, 2012 |
Nuvalent
Jun 9, 2026
Downgraded: Hold
Price Target: n/a
Current: $123.35
Upside: -
BioMarin Pharmaceutical
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $56.17
Upside: -
Climb Bio
May 19, 2026
Maintained: Buy
Price Target: n/a
Current: $10.80
Upside: -
Alumis
Mar 27, 2026
Maintained: Buy
Price Target: $46
Current: $20.06
Upside: +129.31%
Biohaven
Mar 9, 2026
Maintained: Buy
Price Target: n/a
Current: $11.07
Upside: -
Tyra Biosciences
Feb 23, 2026
Maintained: Buy
Price Target: $35 → $55
Current: $25.42
Upside: +116.37%
Regeneron Pharmaceuticals
Jan 30, 2026
Maintained: Buy
Price Target: $723 → $870
Current: $601.65
Upside: +44.60%
Cogent Biosciences
Jan 26, 2026
Maintained: Buy
Price Target: $60
Current: $31.38
Upside: +91.20%
Lexeo Therapeutics
Jan 13, 2026
Maintained: Buy
Price Target: $25
Current: $4.13
Upside: +505.33%
Ardelyx
Jan 8, 2026
Maintained: Buy
Price Target: $14 → $19
Current: $5.61
Upside: +238.68%
Dec 2, 2025
Initiated Coverage: Buy
Price Target: $47
Current: $3.48
Upside: +1,250.57%
Nov 25, 2025
Maintained: Buy
Price Target: $13
Current: $5.40
Upside: +140.74%
Nov 14, 2025
Maintained: Buy
Price Target: $142 → $123
Current: $59.73
Upside: +105.93%
Oct 20, 2025
Initiated Coverage: Buy
Price Target: $26 → $29
Current: $9.14
Upside: +217.29%
Oct 10, 2025
Maintained: Hold
Price Target: n/a
Current: $337.73
Upside: -
Sep 16, 2025
Maintained: Buy
Price Target: $23
Current: $4.18
Upside: +450.24%
Sep 2, 2025
Initiated Coverage: Hold
Price Target: $533 → $401
Current: $435.71
Upside: -7.97%
Feb 18, 2025
Maintained: Buy
Price Target: $13
Current: $4.10
Upside: n/a
Feb 14, 2025
Maintained: Buy
Price Target: $140
Current: $22.97
Upside: n/a
Feb 11, 2025
Downgraded: Hold
Price Target: $20 → $4
Current: $12.87
Upside: n/a
Feb 10, 2025
Maintained: Buy
Price Target: $42
Current: $98.03
Upside: n/a
Jan 27, 2025
Rated: Buy
Price Target: $220 → $227
Current: $224.95
Upside: n/a
Jan 27, 2025
Rated: Buy
Price Target: $75
Current: $9.11
Upside: n/a
Oct 30, 2024
Maintained: Buy
Price Target: $307 → $315
Current: $194.24
Upside: n/a
Oct 23, 2024
Rated: Buy
Price Target: $20
Current: $8.19
Upside: n/a
Oct 23, 2024
Rated: Buy
Price Target: $56
Current: $28.88
Upside: n/a
Sep 16, 2024
Rated: Buy
Price Target: $10
Current: $0.008
Upside: n/a
Aug 9, 2024
Rated: Buy
Price Target: $21 → $8
Current: $1.46
Upside: n/a
Oct 25, 2023
Maintained: Buy
Price Target: $58
Current: $73.38
Upside: n/a
Oct 25, 2023
Maintained: Buy
Price Target: $4
Current: $0.8729
Upside: n/a
Oct 25, 2023
Maintained: Buy
Price Target: $600
Current: $862.18
Upside: n/a
Jul 24, 2023
Rated: Hold
Price Target: $22
Current: $46.74
Upside: n/a
Apr 25, 2023
Maintained: Buy
Price Target: $14
Current: $2.35
Upside: n/a
Nov 22, 2022
Maintained: Hold
Price Target: $28
Current: $0.9315
Upside: n/a
Jul 25, 2022
Initiated Coverage: Buy
Price Target: $28
Current: $38.00
Upside: n/a
May 23, 2022
Maintained: Buy
Price Target: $3
Current: $5.96
Upside: n/a
May 18, 2022
Maintained: Hold
Price Target: $75 → $30
Current: $6.61
Upside: n/a
May 11, 2021
Maintained: Hold
Price Target: $7 → $6
Current: $1.09
Upside: n/a
Apr 13, 2021
Maintained: Buy
Price Target: $8
Current: $30.91
Upside: n/a
Mar 27, 2020
Maintained: Buy
Price Target: n/a
Current: $0.6674
Upside: n/a
Apr 18, 2019
Maintained: Hold
Price Target: n/a
Current: $33.58
Upside: n/a
Aug 7, 2017
Rated: Hold
Price Target: n/a
Current: $3.78
Upside: n/a
Mar 31, 2015
Downgraded: Hold
Price Target: $42 → $101
Current: -
Upside: n/a
Mar 19, 2013
Maintained: Hold
Price Target: n/a
Current: $0.001
Upside: n/a
Feb 29, 2012
Upgraded: Buy
Price Target: $3 → $6
Current: $2.56
Upside: n/a